Spinal cord decompression — a type of spinal surgery — should be done on mucopolysaccharidosis (MPS) patients who have…
Iqra Mumal, MSc
Iqra holds a MSc in Cellular and Molecular Medicine from the University of Ottawa in Ottawa, Canada. She also holds a BSc in Life Sciences from Queen’s University in Kingston, Canada. Currently, she is completing a PhD in Laboratory Medicine and Pathobiology from the University of Toronto in Toronto, Canada. Her research has ranged from across various disease areas including Alzheimer’s disease, myelodysplastic syndrome, bleeding disorders and rare pediatric brain tumors.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Iqra Mumal, MSc
Sarepta Therapeutics has signed a licensing agreement with Lysogene for the development of investigational gene therapy LYS-SAF302 to…
High-dose Genistein Shows No Clinical Benefit for Treating Sanfilippo Children, European Study Shows
Results from a Phase 3 clinical trial evaluating the use of high-dose genistein in children with Sanfilippo syndrome shows…
Brain transplantation of genetically corrected stem cells partially restored enzymatic activity in mice with Sanfilippo syndrome, according to UCLA researchers.
An investigative gene therapy to treat patients with Sanfilippo syndrome type C was developed at the University of Manchester…
A patient with Sanfilippo syndrome and poor nutritional status developed high levels of homocysteine —  an amino acid likely due…
Injecting a modified version of the NAGLU enzyme directly into the brains of mice with Sanfilippo syndrome type B…
Abeona Therapeutics announced that ABO-102 (AAV-SGSH), an investigational therapy for Sanfilippo syndrome type A (MPS IIIA), demonstrated significant and…